EXCLUSIVE: The Department of Health is considering taking steps to require all imported medical cannabis products to be manufactured according to Pharmaceutical Inspection Co-operation Scheme (PIC/S) Good Manufacturing Practice (GMP) quality standards, according to formal correspondence with a medical cannabis licence holder seen by Cannabiz.
According to the Department, consultation on these reforms is expected to commence before the end of 2020.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.